BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 34497233)

  • 1. [Diagnosis and management of pure red cell aplasia].
    Fujishima N
    Rinsho Ketsueki; 2021; 62(8):931-937. PubMed ID: 34497233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recent progress in the diagnosis and management of acquired pure red cell aplasia].
    Ishida F
    Rinsho Ketsueki; 2020; 61(9):1098-1104. PubMed ID: 33162504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and management of pure red cell aplasia].
    Hirokawa M
    Rinsho Ketsueki; 2015 Oct; 56(10):1922-31. PubMed ID: 26458430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progress in the clinical management of pure red cell aplasia and future prospects].
    Hirokawa M
    Rinsho Ketsueki; 2016 Feb; 57(2):110-6. PubMed ID: 26935627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pure red cell aplasia: Diagnosis, classification and treatment].
    Lobbes H
    Rev Med Interne; 2023 Jan; 44(1):19-26. PubMed ID: 36336519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pure red cell aplasia: The second hundred years.
    Means RT
    Am J Med Sci; 2023 Sep; 366(3):160-166. PubMed ID: 37327996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of patients with acquired chronic pure red cell aplasia (PRCA) following immunosuppressive therapy: a final report of the nationwide cohort study in 2004/2006 by the Japan PRCA collaborative study group.
    Hirokawa M; Sawada K; Fujishima N; Teramura M; Bessho M; Dan K; Tsurumi H; Nakao S; Urabe A; Fujisawa S; Yonemura Y; Kawano F; Oshimi K; Sugimoto K; Matsuda A; Karasawa M; Arai A; Komatsu N; Harigae H; Omine M; Ozawa K; Kurokawa M;
    Br J Haematol; 2015 Jun; 169(6):879-86. PubMed ID: 25807974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and pathophysiological features of acquired pure red cell aplasia: based on the concept of T-cell dysregulations].
    Ishida F
    Rinsho Ketsueki; 2022; 63(8):893-898. PubMed ID: 36058860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: a nationwide cohort study in Japan by the PRCA collaborative study group.
    Hirokawa M; Sawada K; Fujishima N; Nakao S; Urabe A; Dan K; Fujisawa S; Yonemura Y; Kawano F; Omine M; Ozawa K;
    Haematologica; 2008 Jan; 93(1):27-33. PubMed ID: 18166782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Possible complications of erythropoietin therapy in patients with chronic renal failure].
    Pljesa S
    Med Pregl; 2004; 57(5-6):254-7. PubMed ID: 15503795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic lymphocytic leukemia-associated pure red cell aplasia.
    D'Arena G; Cascavilla N
    Int J Immunopathol Pharmacol; 2009; 22(2):279-86. PubMed ID: 19505381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pure red cell aplasia.
    Means RT
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):51-56. PubMed ID: 27913462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pure red cell aplasia.
    Means RT
    Blood; 2016 Nov; 128(21):2504-2509. PubMed ID: 27881371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and outcomes of 100 adult patients with pure red cell aplasia.
    Wu X; Cheng L; Liu X; Sun Y; Li B; He G; Li J
    Ann Hematol; 2022 Jul; 101(7):1493-1498. PubMed ID: 35460389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal hematopoiesis in adult pure red cell aplasia.
    Fujishima N; Kohmaru J; Koyota S; Kuba K; Saga T; Omokawa A; Moritoki Y; Ueki S; Ishida F; Nakao S; Matsuda A; Ohta A; Tohyama K; Yamasaki H; Usuki K; Nakashima Y; Sato S; Miyazaki Y; Nannya Y; Ogawa S; Sawada K; Mitani K; Hirokawa M
    Sci Rep; 2021 Jan; 11(1):2253. PubMed ID: 33500526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pure red cell aplasia (PRCA) induced by anti-EPO antibodies: epidemiology, diagnosis and treatment].
    Janda K; Kraśniak A; Krzanowski M; Sułowicz W
    Przegl Lek; 2010; 67(3):187-91. PubMed ID: 20687383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and outcomes of 11 patients with pure red cell aplasia at a single institution over a 13-year period.
    Kawano N; Nagahiro Y; Yoshida S; Yamashita K; Himeji D; Yokota-Ikeda N; Uezono S; Shimao Y; Makino S; Shimoda K; Ueda A
    Intern Med; 2013; 52(18):2025-30. PubMed ID: 24042508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pregnant woman with thymoma-associated pure red cell aplasia.
    Shibata M; Kaneko K; Umehara N; Matsui H; Kawai T; Nakadate H; Murashimia A; Sago H
    BMC Pregnancy Childbirth; 2022 Oct; 22(1):795. PubMed ID: 36303124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiopathic pure red cell aplasia: case report with review of literature.
    Khalife W; Murunga E; Mahmoud F
    S D J Med; 2005 Dec; 58(12):501-5. PubMed ID: 16700352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pure red cell aplasia and lymphoproliferative disorders: an infrequent association.
    Vlachaki E; Diamantidis MD; Klonizakis P; Haralambidou-Vranitsa S; Ioannidou-Papagiannaki E; Klonizakis I
    ScientificWorldJournal; 2012; 2012():475313. PubMed ID: 22593689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.